Lisata Therapeutics, Inc. (LSTA): Operating Cash Flow
-$15.95M
Year ended 2025-12-31
-$12.32M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$15.95M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$19.36M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$20.03M | n/m | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | -$21.17M | n/m | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | -$22.25M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$8.82M | n/m | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | -$18.88M | n/m | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | -$19.99M | n/m | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | -$20.88M | n/m | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | -$23.67M | n/m | 2018-03-22, From 2016-01-01 |
| 2015-12-31 | -$39.26M | n/m | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | -$46.90M | n/m | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | -$27.10M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$13.85M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | -$20.93M | n/m | 2013-03-11, From 2011-01-01 |
| 2010-12-31 | -$8.48M | n/a | 2012-03-20, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$15.95M | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$18.55M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$17.95M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$383.6K | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$5.52M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | -$23.22M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$2.99M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$3.75M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$14.82M | n/m |
Compare LSTA, CLNN, SER, RGBP side by side · Screen every company in Pharmaceutical Preparations ↗